MELINTA THERAPEUTICS INC's ticker is MLNTXXXX and the CUSIP is 58549G100. A total of 89 filers reported holding MELINTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.39 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,282,000 | -79.9% | 1,616,867 | 0.0% | 0.14% | -80.4% |
| Q3 2018 | $6,387,000 | +2.2% | 1,616,867 | +64.2% | 0.73% | -15.0% |
| Q2 2018 | $6,252,000 | +246.4% | 984,492 | +303.7% | 0.86% | +214.6% |
| Q1 2018 | $1,805,000 | -42.9% | 243,896 | +21.9% | 0.27% | -26.1% |
| Q4 2017 | $3,160,000 | – | 200,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISTHMUS PARTNERS, LLC | 84,072 | $7,657,000 | 1.86% |
| Sterling Investment Advisors, Ltd. | 19 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |